Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Firms To Gear Up For Japan’s Approaching OTC Law, Expected Market Growth

This article was originally published in The Tan Sheet

Executive Summary

Firms are preparing for regulations taking effect in April 2009 that are expected to grow Japan's OTC market by allowing for expanded consumer access to nonprescription products

You may also be interested in...



In Japan, Online Retailers Miss Out On OTC Deregulation

Japan expanded consumer access to OTC drugs and some nutritional supplements on June 1, but faces challenges to its ban on online sales of the products

In Japan, Online Retailers Miss Out On OTC Deregulation

Japan expanded consumer access to OTC drugs and some nutritional supplements on June 1, but faces challenges to its ban on online sales of the products

In Japan, Online Retailers Miss Out On OTC Deregulation

Japan expanded consumer access to OTC drugs and some nutritional supplements on June 1, but faces challenges to its ban on online sales of the products

Related Content

Topics

UsernamePublicRestriction

Register

MT142464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel